NRD
WVE icon

Nebula Research & Development’s Wave Life Sciences WVE Stock Holding History

Nebula Research & Development’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-34,342
Closed -$223K – 884
2025
Q2 		$223K Buy
34,342
+2,748
+9% +$18.1K 0.02% 866
2025
Q1 		$255K Buy
31,594
+4,457
+16% +$48.7K 0.02% 805
2024
Q4 		$336K Buy
+27,137
New +$362K 0.04% 683

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Nebula Research & Development's WVE Position: Q3 2025 in Review

Nebula Research & Development sold out of Wave Life Sciences (WVE) in Q3 2025, closing a stake of 34,342 shares — an estimated $223K sold.

Nebula Research & Development first reported a position in WVE in Q4 2024 and held it in 3 quarters. The position peaked at $336K in Q4 2024. 189 funds tracked by Wall St. Rank hold WVE as of Q3 2025.

  • Nebula Research & Development reported no remaining Wave Life Sciences position as of Q3 2025 after selling out during the quarter.
  • Nebula Research & Development sold 34,342 Wave Life Sciences shares in Q3 2025, an estimated $223K.
  • Nebula Research & Development first reported a position in Wave Life Sciences in Q4 2024 and held it in 3 quarters.
  • Nebula Research & Development's Wave Life Sciences position peaked at $336K in Q4 2024.
  • 189 funds tracked by Wall St. Rank held Wave Life Sciences as of Q3 2025.

Based on Nebula Research & Development's 13F filing for Q3 2025.